RT Journal Article
SR Electronic
T1 Overview of maternal morbidity in Morocco Marrakech-Safi region
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2022.09.27.22280423
DO 10.1101/2022.09.27.22280423
A1 Hababa, Hanane
A1 Assarag, Bouchra
YR 2022
UL http://medrxiv.org/content/early/2022/09/27/2022.09.27.22280423.abstract
AB Objectives The measurement of less severe maternal morbidity represents many challenges for women during pregnancy and postpartum, and for the organization of health services. This article aims to test the tools for measuring maternal morbidity less severe proposed by the WHO and describe the state of play of this morbidity at the level of the prefecture of Marrakech. The second phase is to study the feasibility and acceptability of integrating these tools into the Pregnancy and Childbirth Surveillance Program.Methods The analysis focused on the maternal morbidities declared and diagnosed in the test, and related the feasibility and acceptability as well as the relevance of the tools tested.Results Most of the women who participated in the study (55.95% antenatal and 52.17% postpartum care) were not in good health (A medical or obstetric condition is diagnosed). Of these women, 35.79% had direct (obstetric) complications and 33.85% indirect (medical) complications. In terms of feasibility, the results suggest that the implementation of the tools presents challenges in terms of time, resources and coordination. Regarding the acceptability of the WMOs, the women surveyed perceive it as a useful information tool that promotes communication with health professionals and makes it possible to assess their state of health and ensure their holistic care.Conclusion Considering these results, the approach supports the relevance of implementing the MM measure in antenatal and postpartum care to improve the quality of care for women, to promote communication and continuity of care. However, constraints of time, resources and coordination must be taken into account for its implementation at primary health care.Competing Interest StatementThe authors have declared that no competing interests exist.Funding StatementThe authors received no specific funding for this work.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:ethics committee of the faculty of medicine of rabatI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll relevant data are within the manuscriptPoNC(Postnatal consultation)PNC(Prenatal consultation)GD(General Doctor)PHCN(Primary health care Network)PWCP(Pregnant woman care program)OMM(Measuring maternal morbidity)WHO(Word Health Organization)